The expert speakers focus on the fundamental principles and key elements of competition law in the EU and UK that apply to the pharmaceutical industry. This is an interactive session that uses case ...

A San Diego startup may have created what the scientific community has talked about for decades – a kind of universal flu ...

The GLP-1 fight just entered a new round, and it highlights why these three out-of-favor drug makers are worth a deep dive.

Editorial: Over the holiday period, the Guardian leader column is looking ahead at the themes of 2026. Today we examine how the White House’s war on vaccines has left the future of a key technology un ...

Drugmakers plan to raise US prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and ...

Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...

ASCO GU 2025 had groundbreaking advancements in genitourinary cancer treatments, focusing on prostate cancer, renal cell ...

According to healthcare research firm 3 Axis Advisors, drugmakers are planning to raise U.S. prices on medications including ...

Jim Cramer has built a strong reputation in the industry. He’s the Mad Money host who carefully picks growth stocks that have ...

The president is fighting two wars: a global trade reset that restores the dignity of the American working class, and a ...

In 2026, a new president will take over the reins of government. A deranged, narcissistic dictator will be installed at Aso Rock. His party will staunchly stand by him through every insane ...